Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Pozzilli

Showing results (151-160 of 247) with videos related to

Pageof 25
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2020
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosisLuca Prosperini, Chiara Mancinelli, Shalom Haggiag, et al.
Journal of Neurology|April 17, 2002
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosisCarlo Pozzilli, Giovanni Antonini, Francesca Bagnato, et al.
Human Brain Mapping|March 19, 2016
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidenceValentina Tomassini, Alessandro d'Ambrosio, Nikolaos Petsas, et al.
European Journal of Pain (London, England)|July 8, 2008
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosisAntonella Conte, Chiara Marini Bettolo, Emanuela Onesti, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 4, 2015
Oral contraceptives combined with interferon β in multiple sclerosisCarlo Pozzilli, Laura De Giglio, Valeria T Barletta, et al.
Biomedicines|February 25, 2022
Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes?Daniele Belvisi, Matteo Tartaglia, Giovanna Borriello, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 23, 2020
Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS studyGiancarlo Comi, Carlo Pozzilli, Vincenzo Brescia Morra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 17, 2020
The introduction of new medications in pediatric multiple sclerosis: Open issues and challengesAngelo Ghezzi, Maria Pia Amato, Gilles Edan, et al.
European Journal of Neurology|April 15, 2025
Generics, Biosimilars and Follow-On Non-Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European NeurologistsThomas Berger, Markus Zeitlinger, Veronica Popescu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 22, 2020
Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19Antonio Carotenuto, Laura De Giglio, Alessandro Chiodi, et al.
Pageof 25

Showing results (151-160 of 247) with videos related to

Sort By:
Pageof 25
Journal of Neurology, Neurosurgery, and Psychiatry|January 25, 2020
Minimal evidence of disease activity (MEDA) in relapsing-remitting multiple sclerosisLuca Prosperini, Chiara Mancinelli, Shalom Haggiag, et al.
Journal of Neurology|April 17, 2002
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosisCarlo Pozzilli, Giovanni Antonini, Francesca Bagnato, et al.
Human Brain Mapping|March 19, 2016
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidenceValentina Tomassini, Alessandro d'Ambrosio, Nikolaos Petsas, et al.
European Journal of Pain (London, England)|July 8, 2008
Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosisAntonella Conte, Chiara Marini Bettolo, Emanuela Onesti, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 4, 2015
Oral contraceptives combined with interferon β in multiple sclerosisCarlo Pozzilli, Laura De Giglio, Valeria T Barletta, et al.
Biomedicines|February 25, 2022
Are Neurophysiological Biomarkers Able to Discriminate Multiple Sclerosis Clinical Subtypes?Daniele Belvisi, Matteo Tartaglia, Giovanna Borriello, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|April 23, 2020
Effectiveness of fingolimod in real-world relapsing-remitting multiple sclerosis Italian patients: the GENIUS studyGiancarlo Comi, Carlo Pozzilli, Vincenzo Brescia Morra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 17, 2020
The introduction of new medications in pediatric multiple sclerosis: Open issues and challengesAngelo Ghezzi, Maria Pia Amato, Gilles Edan, et al.
European Journal of Neurology|April 15, 2025
Generics, Biosimilars and Follow-On Non-Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European NeurologistsThomas Berger, Markus Zeitlinger, Veronica Popescu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 22, 2020
Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19Antonio Carotenuto, Laura De Giglio, Alessandro Chiodi, et al.
Pageof 25